September 25, 2020
Once-Weekly Insulin Icodec Promising for Type 2 Diabetes
FRIDAY, Sept. 25, 2020 (HealthDay News) — For patients with type 2 diabetes, once-weekly insulin icodec has glucose-lowering efficacy comparable to once-daily insulin glargine, according to a study published online Sept. 22 in the New England Journal of Medicine to coincide with the European Association for the Study of Diabetes, held virtually from Sept. 21...
Rheumatoid Arthritis Linked to Higher Risk for Type 2 Diabetes
FRIDAY, Sept. 25, 2020 (HealthDay News) — Rheumatoid arthritis (RA) is associated with an increased risk for diabetes mellitus (DM) incidence, according to research presented at the annual meeting of the European Association for the Study of Diabetes, held virtually from Sept. 21 to 25. Zixing Tian, from the University of Manchester in the United...
Diagnoses of Common Conditions Declined in March to May 2020
FRIDAY, Sept. 25, 2020 (HealthDay News) — Diagnoses of common conditions decreased substantially between March and May 2020, according to a study published online Sept. 23 in The Lancet Public Health. The research was published to coincide with the European Society of Clinical Microbiology and Infectious Diseases Conference on Coronavirus Diseases, held virtually from Sept....